ATE201678T1 - Naphthalenamide als leukotrien antagonisten - Google Patents
Naphthalenamide als leukotrien antagonistenInfo
- Publication number
- ATE201678T1 ATE201678T1 AT95929014T AT95929014T ATE201678T1 AT E201678 T1 ATE201678 T1 AT E201678T1 AT 95929014 T AT95929014 T AT 95929014T AT 95929014 T AT95929014 T AT 95929014T AT E201678 T1 ATE201678 T1 AT E201678T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrogen
- bound
- group
- chlorine
- fluorine
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- RMHJJUOPOWPRBP-UHFFFAOYSA-N naphthalene-1-carboxamide Chemical compound C1=CC=C2C(C(=O)N)=CC=CC2=C1 RMHJJUOPOWPRBP-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene-acid Natural products C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical group C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- -1 Naphthalene amides Chemical class 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 229950011260 betanaphthol Drugs 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002617 leukotrienes Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES09401696A ES2103181B1 (es) | 1994-08-01 | 1994-08-01 | Amidas naftalenicas con accion antagonista de los leucotrienos. |
| PCT/EP1995/002970 WO1996004267A1 (en) | 1994-08-01 | 1995-07-27 | Naphthalene amides having leukotriene-antagonistic action |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201678T1 true ATE201678T1 (de) | 2001-06-15 |
Family
ID=8287122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95929014T ATE201678T1 (de) | 1994-08-01 | 1995-07-27 | Naphthalenamide als leukotrien antagonisten |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0775133B1 (de) |
| AT (1) | ATE201678T1 (de) |
| AU (1) | AU3253995A (de) |
| DE (1) | DE69521132T2 (de) |
| ES (2) | ES2103181B1 (de) |
| GR (1) | GR3036462T3 (de) |
| PT (1) | PT775133E (de) |
| WO (1) | WO1996004267A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2117551B1 (es) * | 1995-12-29 | 1999-04-01 | Menarini Lab | Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas. |
| ES2150848B1 (es) * | 1998-04-15 | 2001-07-01 | Menarini Lab | Heterociclos metiloxinaftil sustituidos con accion antagonista de los leucotrienos. |
| TWI262185B (en) * | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| PL362320A1 (en) * | 2000-12-06 | 2004-10-18 | Aventis Pharma Deutschland Gmbh | Guanidine and amidine derivatives as factor xa inhibitors |
| JP4212358B2 (ja) * | 2000-12-28 | 2009-01-21 | 第一三共株式会社 | Ｖｌａ−４阻害薬 |
| TW591020B (en) * | 2001-06-20 | 2004-06-11 | Wyeth Corp | 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| GB2405146A (en) * | 2002-06-07 | 2005-02-23 | Cortical Pty Ltd | Napthalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) |
| CA2528586A1 (en) | 2003-07-24 | 2005-02-03 | Daiichi Pharmaceutical Co., Ltd. | Cyclohexanecarboxylic acid compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579866A (en) * | 1984-05-29 | 1986-04-01 | Usv Pharmaceutical Corp. | Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents |
| US5084575A (en) * | 1987-07-31 | 1992-01-28 | American Home Products Corporation | Quinoline substituted naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents |
| US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920131A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
-
1994
- 1994-08-01 ES ES09401696A patent/ES2103181B1/es not_active Expired - Lifetime
-
1995
- 1995-07-27 DE DE69521132T patent/DE69521132T2/de not_active Expired - Fee Related
- 1995-07-27 WO PCT/EP1995/002970 patent/WO1996004267A1/en not_active Ceased
- 1995-07-27 ES ES95929014T patent/ES2156944T3/es not_active Expired - Lifetime
- 1995-07-27 EP EP95929014A patent/EP0775133B1/de not_active Expired - Lifetime
- 1995-07-27 AT AT95929014T patent/ATE201678T1/de not_active IP Right Cessation
- 1995-07-27 AU AU32539/95A patent/AU3253995A/en not_active Abandoned
- 1995-07-27 PT PT95929014T patent/PT775133E/pt unknown
-
2001
- 2001-08-29 GR GR20010401313T patent/GR3036462T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT775133E (pt) | 2001-10-30 |
| WO1996004267A1 (en) | 1996-02-15 |
| ES2103181B1 (es) | 1998-04-01 |
| GR3036462T3 (en) | 2001-11-30 |
| ES2156944T3 (es) | 2001-08-01 |
| DE69521132D1 (de) | 2001-07-05 |
| AU3253995A (en) | 1996-03-04 |
| ES2103181A1 (es) | 1997-08-16 |
| EP0775133B1 (de) | 2001-05-30 |
| EP0775133A1 (de) | 1997-05-28 |
| DE69521132T2 (de) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY131297A (en) | Herbicides | |
| YU49122B (sh) | Supstituisana benzilaminopiperidinska jedinjenja | |
| MY110447A (en) | New herbicides | |
| YU74892A (sh) | Novi herbicidi | |
| AU2002327747A1 (en) | Substituted pentacene semiconductors | |
| NO20051207L (no) | Proteinkinaseinhibitorer og anvendelser derav | |
| ATE201678T1 (de) | Naphthalenamide als leukotrien antagonisten | |
| YU74792A (sh) | Herbicidi | |
| EP0776208A4 (de) | 2,3-dihydro-1-(2,2,2-trifluorethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepine | |
| DK0667856T3 (da) | Nye D-vitaminanaloger | |
| ATE244215T1 (de) | Flüssigkristalline verbindungen | |
| ATE215937T1 (de) | Oxazolidinedion-derivate und ihre anwendung als hypoglykämisches mittel | |
| DE60011269D1 (de) | Azaidole mit serotonin rezeptor affinität | |
| DE69412016D1 (de) | Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| BR9403975A (pt) | Preparados cosméticos e suas aplicações | |
| ATE223226T1 (de) | Azazyklohexapeptid-verbindungen | |
| DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| UA41350C2 (uk) | Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі | |
| ES2103180A1 (es) | Fenilacetamidas con accion antagonista de los leucotrienos. | |
| DE59907215D1 (de) | Substituierte benzimidazole, ihre herstellung und ihre verwendung als mittel gegen parasitäre protozoen | |
| NO954633D0 (no) | Nye kromenforbindelser | |
| NO943861L (no) | Trisyklisk forbindelse til bruk som tachykinin-antagonist | |
| ATE198330T1 (de) | Saccharinderivate und ihre anwendung als herbizide | |
| DK1037871T3 (da) | Nye antiarytmiske forbindelser | |
| ES2117551A1 (es) | Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |